AAD 2022 – New Long-Term Bimekizumab Complete Skin Clearance Data in Moderate to Severe Plaque Psoriasis in Adults
Returning guest, Dr. Jeff Stark, Head of US Medical Immunology at UCB, discusses new long-term complete skin clearance data for bimekizumab in the treatment of moderate to severe plaque psoriasis in adults that was presented at the American Academy of Dermatology (AAD) Annual Meeting 2022.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Treatment. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Treatment and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Treatment?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Jeff Stark, Head of US Medical Immunology at UCB, discusses new long-term complete skin clearance data for bimekizumab in the treatment of moderate to severe plaque psoriasis in…
- Key Point: After completing training at Vanderbilt University and Emory University, he spent several years in full-time rheumatology practice in both private and academic clinical settings.
- Key Point: In subsequent industry medical affairs roles, Dr.
- Key Point: Stark has focused on medical education, advocacy, data generation, and highlighting the unmet needs of patients with immunologic diseases.
- Key Point: Stark serves as a board member of the American College of Rheumatology (ACR) Research Foundation and is a member of the Medical Advisory Board of the Georgia Chapter of the Lupu…
Jeffrey Stark, MD, is the Head of Medical Immunology at UCB and is board-certified in both rheumatology and internal medicine. After completing training at Vanderbilt University and Emory University, he spent several years in full-time rheumatology practice in both private and academic clinical settings. In subsequent industry medical affairs roles, Dr. Stark has focused on medical education, advocacy, data generation, and highlighting the unmet needs of patients with immunologic diseases. In addition to his role at UCB, Dr. Stark serves as a board member of the American College of Rheumatology (ACR) Research Foundation and is a member of the Medical Advisory Board of the Georgia Chapter of the Lupus Foundation. Dr. Stark is also a past President of the Georgia Society of Rheumatology.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



